China Kicks Off Pharmaceutical Manufacturing And Innovation Project
This article was originally published in PharmAsia News
A task force comprising members from China's Ministry of Health and 10 governmental bodies has proposed pharmaceutical manufacturing and innovation guidelines under the national science and technology development program. The project has two key targets, first of which is the development of a batch of medical products that are safe, efficient, convenient and cheap to prevent and treat major diseases. The second is the development of innovative drugs with intellectual property rights and market competitiveness, building up of advanced technology platforms, as well as shaping new drug creativity and technology systems to support the nation's pharmaceutical innovation. (Click here for more - Chinese Language)
You may also be interested in...
China's Ministry of Science and Technology has officially started implementing the new drug innovation and production project to become a pharmaceutical powerhouse (PharmAsia News, Sept. 8, 2008). The country's program with the highest investment, has allocated RMB 5.3 billion ($775 million) for a total of 970 research topics. The first batch of 121 topics with funding of RMB 1 billion has commenced. The second batch of 849 topics which will use the remaining funds has been identified and are ready to go. Sang Guo-wei, chief technology director for the program, stated that chemical drugs will be the emphasis, biopharmaceutical products the highlight and TCM the unique feature. (Click here for more - Chinese language)
According to the China Pharmaceutical Technology Transfer Center and the China Pharmaceutical Technology Organization, a Dec. 7 national advanced pharmaceutical technology management training class will focus on process management in the pharmaceutical manufacturing and innovation project (PharmAsia News, Sep. 8, 2008) under the country's 11th Five-Year Plan (2006-2010). At present, work on the first batch of project applications has been completed and the acceptance list will be publicized soon. A total of 3,290 proposed projects for the second batch are under appraisal and classes will begin next year. Subjects cover pivotal technology research in new drug development, establishment of technology platforms for drug innovation and construction of new drug incubation centers for enterprises. (Click here for more - Chinese Language)
SHANGHAI - China will invest RMB 6.6 billion ($960 million) to launch a massive new drug development and manufacturing program from 2008 to 2010. Roughly 3,290 projects focused on preclinical studies and identifying new candidates are awaiting approval to initiate in 2009